These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 34365926)

  • 1. Molecular Changes in the Glucokinase Gene (GCK) Associated with the Diagnosis of Maturity Onset Diabetes of the Young (MODY) in Pregnant Women and Newborns.
    Lepore C; Damaso E; Suazo V; Queiroz R; Junior RL; Moisés E
    Curr Diabetes Rev; 2022; 18(6):e060821195358. PubMed ID: 34365926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy in Women With Monogenic Diabetes due to Pathogenic Variants of the Glucokinase Gene: Lessons and Challenges.
    Timsit J; Ciangura C; Dubois-Laforgue D; Saint-Martin C; Bellanne-Chantelot C
    Front Endocrinol (Lausanne); 2021; 12():802423. PubMed ID: 35069449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation.
    Chakera AJ; Steele AM; Gloyn AL; Shepherd MH; Shields B; Ellard S; Hattersley AT
    Diabetes Care; 2015 Jul; 38(7):1383-92. PubMed ID: 26106223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of the glucokinase impaired function - GCK MODY today.
    Hulín J; Škopková M; Valkovičová T; Mikulajová S; Rosoľanková M; Papcun P; Gašperíková D; Staník J
    Physiol Res; 2020 Dec; 69(6):995-1011. PubMed ID: 33129248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of GCK-maturity-onset diabetes of the young in cases of neonatal hyperglycemia: A case series and review of clinical features.
    Hughes AE; De Franco E; Globa E; Zelinska N; Hilgard D; Sifianou P; Hattersley AT; Flanagan SE
    Pediatr Diabetes; 2021 Sep; 22(6):876-881. PubMed ID: 34085361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bringing precision medicine to the management of pregnancy in women with glucokinase-MODY: a study of diagnostic accuracy and feasibility of non-invasive prenatal testing.
    Hughes AE; Houghton JAL; Bunce B; Chakera AJ; Spyer G; Shepherd MH; Flanagan SE; Hattersley AT
    Diabetologia; 2023 Nov; 66(11):1997-2006. PubMed ID: 37653058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY).
    Li X; Ting TH; Sheng H; Liang CL; Shao Y; Jiang M; Xu A; Lin Y; Liu L
    BMC Pediatr; 2018 Mar; 18(1):101. PubMed ID: 29510678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Course of pregnancy and 10-year observation of twins diagnosed with GCK-MODY in the neonatal period: a case report.
    Katra B; Szopa M
    Front Endocrinol (Lausanne); 2024; 15():1395424. PubMed ID: 39411314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management and pregnancy outcomes of women with GCK-MODY enrolled in the US Monogenic Diabetes Registry.
    Dickens LT; Letourneau LR; Sanyoura M; Greeley SAW; Philipson LH; Naylor RN
    Acta Diabetol; 2019 Apr; 56(4):405-411. PubMed ID: 30535721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caudal regression syndrome in a fetus of a glucokinase-maturity-onset diabetes of the young pregnancy.
    Taylor RAM; Mackie A; Mogra R; Pinner J; Rajendran S; Ross GP
    Diabet Med; 2019 Feb; 36(2):252-255. PubMed ID: 30362177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucokinase-maturity onset diabetes mellitus in the young suggested by factory-calibrated glucose monitoring data: a case report.
    Nomura N; Iizuka K; Goshima E; Hosomichi K; Tajima A; Kubota S; Liu Y; Takao K; Kato T; Mizuno M; Hirota T; Suwa T; Horikawa Y; Yabe D
    Endocr J; 2022 Apr; 69(4):473-477. PubMed ID: 34803122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucokinase Deficit Prevalence in Women With Diabetes in Pregnancy: A Matter of Screening Selection.
    Bitterman O; Giuliani C; Festa C; Napoli A
    Front Endocrinol (Lausanne); 2020; 11():268. PubMed ID: 32508747
    [No Abstract]   [Full Text] [Related]  

  • 13. Glucokinase gene mutations (MODY 2) in Asian Indians.
    Kanthimathi S; Jahnavi S; Balamurugan K; Ranjani H; Sonya J; Goswami S; Chowdhury S; Mohan V; Radha V
    Diabetes Technol Ther; 2014 Mar; 16(3):180-5. PubMed ID: 24405491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The glucokinase mutation p.T206P is common among MODY patients of Jewish Ashkenazi descent.
    Gozlan Y; Tenenbaum A; Shalitin S; Lebenthal Y; Oron T; Cohen O; Phillip M; Gat-Yablonski G
    Pediatr Diabetes; 2012 Sep; 13(6):e14-21. PubMed ID: 21978167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical management of hyperglycemia in pregnancy complicated by maturity-onset diabetes of the young.
    Bacon S; Schmid J; McCarthy A; Edwards J; Fleming A; Kinsley B; Firth R; Byrne B; Gavin C; Byrne MM
    Am J Obstet Gynecol; 2015 Aug; 213(2):236.e1-7. PubMed ID: 25935773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical profiling and screening for HNF4α and GCK gene mutations in Kashmiri patients with maturity-onset diabetes of the young (MODY).
    Firdous P; Hassan T; Nissar K; Masoodi SR; Ganai BA
    Prim Care Diabetes; 2022 Apr; 16(2):325-332. PubMed ID: 35131168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort.
    Chakera AJ; Spyer G; Vincent N; Ellard S; Hattersley AT; Dunne FP
    Diabetes Care; 2014; 37(5):1230-6. PubMed ID: 24550216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk assessment by coronary artery calcium score in subjects with maturity-onset diabetes of the young caused by glucokinase mutations.
    Franco LF; Szarf G; Dotto RP; Dib SA; Moises RS; Giuffrida FMA; Reis AF
    Diabetes Res Clin Pract; 2021 Jun; 176():108867. PubMed ID: 34023340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic deletion of a short fragment of glucokinase in rabbit by CRISPR/Cas9 leading to hyperglycemia and other typical features seen in MODY-2.
    Song Y; Sui T; Zhang Y; Wang Y; Chen M; Deng J; Chai Z; Lai L; Li Z
    Cell Mol Life Sci; 2020 Aug; 77(16):3265-3277. PubMed ID: 31720743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
    Gloyn AL
    Hum Mutat; 2003 Nov; 22(5):353-62. PubMed ID: 14517946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.